Psilocybin Newspaper Coverage – Sentiment and Frequency (1989-2020)

This review (2021) explored coverage of psilocybin in four major American newspapers. It was found that the number of articles mentioning psilocybin increased significantly in only one of the newspapers, The New York Times. It was concluded that the increasing optimism surrounding psilocybin may be premature and findings from psilocybin research should be shared outside of the psychedelic community.

Abstract

“A growing body of medical research has focused on the chemical compound psilocybin in recent years. However, this research is not merely a scientific issue but also a social and political one. In the 1960s, psilocybin and other psychedelics were often ingested outside of research settings. This alarmed many people, resulting in severe legal restrictions on psilocybin research. Today, many psilocybin advocates hope that it will avoid the negative public sentiment of the 1960s. To help gauge public sentiment about other psychoactive compounds, some studies have examined newspaper coverage. The present study hoped to build a similar gauge with newspaper coverage of psilocybin. The author hypothesized that general sentiment about psilocybin has become more positive among American newspapers in recent years and that the annual number of newspaper articles mentioning psilocybin has increased. To test these hypotheses, all mentions of psilocybin were examined in four regional American newspapers from January 1, 1989, to December 31, 2020. Contrary to the hypotheses, a significant rise in positive sentiment was seen in only one of these newspapers, and the annual number of articles mentioning psilocybin significantly increased in only one newspaper. These results could be a warning to psilocybin advocates about the risk of negative social and political sentiment growing again.”

Abstract: Dax Oliver

Summary of Psilocybin Newspaper Coverage – Sentiment and Frequency (1989-2020)

Introduction

Psilocybin is a chemical compound found in several species of fungus. It binds to serotonin receptors in the brain and is believed to be correlated with psychedelic experiences.

In the 1950s and 1960s, a number of research studies were conducted about psilocybin, including studies on color perception, spiritual emotions of divinity students, and criminal recidivism. Timothy Leary promoted psychedelic use, but a social backlash developed, and psilocybin was listed as a Schedule 1 drug in 1970.

To access this content, you must purchase one of the following memberships: Sprout Membership, Pro Membership, Pro Membership Unlimited, Business Membership or Business Membership Unlimited. The membership will give you access to exclusive data, including summaries of psychedelic research papers, extended company info, and our member-only visualisations. Save yourself multiple hours each week by accessing Blossom’s resource library.

Study details

Compounds studied
Psilocybin

Topics studied
Safety

Study characteristics
Literature Review